ETFs
Below are funds with Lineage Cell Therapeutics, Inc. stocks, sorted by market value. Equipped with price, change, and other helpful stats, they make investing in stocks more accessible and offer more opportunities at a lower risk.
Symbol | Market value | Weight | Issuer | Management style | Focus | Expense ratio | AUM | Price | Change % | Rel Volume | NAV total return 3Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
 TCH.F85Tachlit SAL (40) TA Growth | 255.86 K USD | 1.19% | Meitav Investment House Ltd. | Passive | Mid cap | 1.03% | 22.81 M USD | 1,956 ILA | +0.41% | 6.24 | +21.14% |
 KSM.F75KSM ETF (4A) TA Global-BlueTech Units | 95.05 K USD | 0.86% | KSM Mutual Funds Ltd. | Passive | Theme | 0.43% | 12.75 M USD | 4,076 ILA | +0.52% | 0.49 | — |
| KSM.F21KSM ETF (4A) TA-Growth | 65.19 K USD | 1.38% | KSM Mutual Funds Ltd. | Passive | Extended market | 1.03% | 5.22 M USD | 19,240 ILA | +0.10% | 1.16 | — |
 MTF.F18MTF SAL (4A) TA Tech - Elite IL | 23.17 K USD | 0.15% | Migdal Insurance & Financial Holdings Ltd. | Active | Information technology | 0.28% | 18.18 M USD | 608.3 ILA | +0.46% | 0.08 | +66.69% |